Afya (NASDAQ:AFYA) VP Gomiero Mirella Basolli Sells 10,000 Shares

Afya Limited (NASDAQ:AFYA) VP Gomiero Mirella Basolli sold 10,000 shares of the stock in a transaction on Friday, June 26th. The shares were sold at an average price of $14.80, for a total value of $148,000.00. Following the completion of the transaction, the vice president owned 34,530 shares in the company, valued at $511,044. The trade was a 22.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Afya Stock Down 0.2%

NASDAQ AFYA opened at $14.84 on Wednesday. The stock has a market capitalization of $1.39 billion, a P/E ratio of 9.70, a price-to-earnings-growth ratio of 1.53 and a beta of 0.34. Afya Limited has a 52 week low of $13.00 and a 52 week high of $18.16. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a fifty day moving average of $14.31 and a 200-day moving average of $14.53.

Hedge Funds Weigh In On Afya

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Daiwa Securities Group Inc. acquired a new position in shares of Afya during the 4th quarter worth about $43,000. Militia Capital Partners LP bought a new position in Afya during the 2nd quarter worth approximately $71,000. Quantbot Technologies LP acquired a new position in Afya during the second quarter valued at approximately $117,000. State of Wyoming acquired a new position in Afya during the second quarter valued at approximately $164,000. Finally, Van ECK Associates Corp increased its stake in Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after purchasing an additional 1,377 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a report on Monday, April 20th. Zacks Research lowered shares of Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. dropped their price target on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. Bank of America restated a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Finally, Wall Street Zen cut shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. One investment analyst has rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $17.10.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.